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ABSTRACT
￿
Receptor-mediated hepatic uptake of low density lipoproteins (LDL) conjugated to
colloidal gold was studied by perfusion of livers from rats treated for 5 d with 17a-ethinyles-
tradiol . Estrogen treatment resulted in a marked decrease in serum lipid and lipoprotein
concentrations. After 15 min of perfusion the conjugate was bound to the hepatic microvilli of
both control and estrogen-treated rats; the estrogen-treated rats showed an 8- to 11-fold greater
number of membrane-bound conjugates. The conjugates were bound to the membrane
receptor by the LDL particle because the gold granules were regularly displaced from the
membrane by 20 ± 3.2 nm, the diameter of LDL. Internalization of the conjugate, evident by
gold particles in multivesicular bodies, occurred at coated pits at the base of the microvillus
where coated vesicles containing a single gold-LDL conjugate were released . After 1 h of
perfusion, the livers from the estrogen-treated rats showed all phases of endocytosis and
incorporation into multivesicular bodies of the conjugate. After 2 h of perfusion, there was
congregation of gold-labeled lysosomes near the bile canaliculi . Gold-LDL conjugates were
also observed to bind and be internalized by Kupffer cells and sinusoidal endothelium.
These findings in,~icate that estrogen treatment induces hepatic receptors for LDL. The
catabolic pathway of binding and endocytosis of the conjugate is similar to that seen in
fibroblasts, although slower. Because gold-LDL conjugates were also present in the Kupffer
and endothelial cells, the uptake of LDL by the liver involves the participation of more than a
single cell type.
The catabolism of low density lipoproteins (LDL) has been
studied in cultured human fibroblasts (3) and other extrahe-
patic tissues (7). The binding of LDL to cells is mediated by a
high-affinity membrane receptor (2, 4), after which the LDL is
internalized and catabolized in the lysosome (7). Because the
liver plays a central role in lipoprotein metabolism, one ques-
tion of importance is whether a similar process of binding,
endocytosis, and lysosomal catabolism of LDL occurs in the
liver.
The perfused rat liver is a useful system to study hepatic
uptake and catabolism oflipoproteins. However, the liverdoes
not express a large number of LDL receptors (24), and repro-
ducible measurements of binding constants and other param-
eters of LDL-receptor interactions are difficult to obtain (8).
Recently, 17«-ethinylestradiol was shown to stimulate hepatic
lipoprotein catabolism, presumably by increasing the number
778
of LDL receptors on the parenchymal cell membrane (8).
Results from studies of perfused livers of estradiol-treated rats
(8) and isolated membranes from livers of treated rats (24)
suggest that the enhanced catabolic activity is attributable to
an increased number of hepatic receptors (three- to tenfold)
for LDL. These estradiol-induced receptors exhibit several
properties analogous to the LDL receptor system as described
for fibroblast cells (42) and are believed responsible for the
enhanced in vivo uptake of LDL by livers of estradiol-treated
rats (8). Although there are similarities between the estradiol-
induced LDL receptor in parenchymal cells and the fibroblast
LDL receptor, the cellular mechanisms related to hepatic bind-
ing and catabolism of LDL are unknown.
We have developed a new ultrastructural probe, a colloidal
gold-LDL conjugate, to study receptor-mediated uptake and
degradation of LDL by cultured human fibroblasts (18). The
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molecules that are clustered around a central 19-rim gold
particle (17). The gold particles are nondegradable, electron-
dense, and easily visualized by transmission electron micros-
copy. In this study, we have used this conjugate in perfusions
of rat livers of estradiol-treated animals to investigate the
binding, endocytosis, and catabolism of LDL. Quantitative
biochemical results ofestradiol treatment on serum lipoproteins
and electron micrographs detailing the time-dependent account
of hepatic internalization of the gold-LDL conjugate are pre-
sented. These results provide correlative evidence that the
enhanced hepatic catabolism of LDL resulting from 17a-eth-
inylestradiol administration may involve an increased number
of membrane receptors for this lipoprotein.
MATERIALS AND METHODS
Materials
17a-ethinylestradiol and bovine serum albumin (Fraction V) were obtained
from Sigma Chemical Co. (St. Louis, Mo.).
Preparation of LDL
LDL (d, 1.019-1.063 g/ml) was isolated from human serum by differential
ultracentrifugation (20). TheLDLwas washed by recentrifugation at the higher
density limit and dialyzed against 0.05% EDTA at pH 7.0.
Preparation of Colloidal Gold-LDL
Colloidal gold was prepared by the method of Frens (15) and conjugated to
LDL, as previously described (18). For perfusion studies, 100 ml ofcolloidal gold
was conjugated to 1.5 mg ofLDLprotein. This volume was condensed by Biogel
dehydration to final volume of20 ml, which contained -7.5 x 10'2 conjugates/
ml. Before perfusion, the conjugate was dialyzed against Krebs-Ringer bicarbon-
ate buffer.
Chemical Analysis
Protein was determined by a modification of the method of Lowry et al. (25).
Cholesterol was assayed by the method of Abell et al. (1). Lipids were extracted
according to the method ofFolch et al. (14) for the determination oftriglycerides
and phospholipids.Triglycerides were measured bythe procedure ofVan Handel
and Zilversmit, as modified by VanHandel (35). Phospholipids were determined
by the method ofZilversmit and Davis (45).
Liver Perfusion
The animals used here were male Sprague-Dawley rats (Charles River,
Wilmington, Mass.) weighing 200-250 g and fed standard Purina Chow ad
libitum. Onegroup of rats was treated with 17a-ethinylestradiol (5 mg/kg body
weight) dissolved in 0.2 ml of propylene glycol, by subcutaneous injection daily
for 5 d. A second group was sham-injected with 0.2 ml of propylene glycol. The
rats were anesthetized by an intraperitoneal injection ofsodium pentobarbital (5
mg/100 g body weight). An aliquot ofblood was obtained from the tail vein for
analysis ofserum cholesterol concentration. After opening the peritoneal cavity,
the common bile duct was cannulated, followed by rapid cannulations of the
portal vein and inferior vena cava. Livers were perfused in situ in a constant
temperature cabinet at 37°C, using amodification of the method of Mortimore
(27) with a membrane oxygenator (16). The perfusate contained washed bovine
erythrocytes at a 22% hematocrit in Krebs-Ringer bicarbonate buffer with 100
mg/dl glucose and 1 g/dl bovine serum albumin, equilibrated with 95%02 and
5% C02 at pH 7.4. The livers were flushed with 100 ml of perfusate and then
perfused in a recirculating system with 80 ml of perfusate. Flow was 1-2 ml/
min/g liverwith a hydrostatic pressure of12-14 cmwater. For uptake studies, 20
ml of the colloidal gold-LDL was added to the reservoir after a 20 min of
perfusion. The final perfusate (100 ml volume) contained 15 fg LDLprotein/ml
that was conjugated to 1.5 x 10'2 conjugates/ml. Recirculating perfusion was
continued for 15 minfor control livers and 15, 60, and 120 min for the estradiol-
treated livers. Viability of the livers was monitored by measurements of arterio-
venous 02 differences during the perfusion with the use of an Instrumentation
Laboratory blood gas analyzer. A-2 ml aliquot ofperfusate was removed from
the reservoir every 15 minduring the perfusion and cleared ofred blood cells by
centrifugation. Therelative amount ofgold-LDL remaining in the perfusate was
calculated by measuring absorbance at 525 rim (21) and relating it to a standard
curve obtained by diluting perfusate samples at time = 0 h. The remaining
amount ofLDL (hg protein/ml) was calculated from the amount of remaining
gold and converting this spectrophotometric measurement to represent remaining
conjugated LDL.
Several competitive binding studies were conducted with livers from estrogen-
treated rats using a 20-fold excess ofunlabeled LDL(300 I+g LDLprotein/ml) in
the presence ofthe gold-LDL conjugate (15 Pg LDLprotein/ml). Recirculating
perfusion was continued for 15 and 60 min, afterwhich the livers were prepared
for electron microscopy (below).
Electron Microscopy
Perfusion fixation (0.5% glutaraldehyde in 0.15 M Na-cacodylate, pH 7.38,
382 mOsm) was performed immediately after the specific perfusion time by
injection into the portal vein cannula at a flow rate and pressure equal to those
used during the perfusion study. Good fixationwasindicated by a homogeneous
discolorationofthe liver and a concomitant hardening ofthe tissue (within 20-40
s). After an initial fixation for 5 min, the perfusion fixative was changed to
buffered 3% glutaraldehyde and 1% acrolein (540mOsm) for 1 h. Theentire liver
was removed, cut into 1-mm cubes, and rinsed with several changes of buffer.
Immersion postfixation(2 h)was done in 1% OS04incacodylatebuffercontaining
0.1% ruthenium red that had been allowed to stand for 3 h before use (19).
During this 3-h aging, ruthenium red is oxidized to a ruthenium nitrosyl com-
pound (l2) which we have found to impart superior contrast to the LDL
moleculesofthe conjugate positionedatthe surface receptor (18). Tissue agitation
was used to minimize a fixation gradient. The samples treated with oxidized
ruthenium red were en bloc stained with 2% uranyl acetate for 2 h, dehydrated,
and embedded in Spures resin (32). In each experiment, several representative
tissue samples from normal and estrogen-treated animals were removed and
prepared for ultrastructural viability tests using ruthenium red (6) or horseradish
peroxidase (23) as electron-dense tracers to identify cellular membrane damage.
Thus, after postfixation in a freshly prepared OsO,-ruthenium red solution,
cellular viability was determined on the basis of membrane exclusion of the
ruthenium stain (6). Likewise, after postfixation in 1% OSO,, the specimen was
immersed in a 0.1% horseradish peroxidase solution. Diaminobenzidine cyto-
chemistry was usedto observe ultrastructural localization of the enzyme. Asboth
methods are based onexclusion ofthe tracers, intracellular accumulation ofeither
ruthenium red or horseradish peroxidase (evidenced by increased overall cell
density) was interpreted to indicate loss of cellular integrity. Thin sections (40
nm) were contrasted with 6% uranyl magnesium followed by lead citrate and
viewed under a Zeiss 9S electron microscope at 60 kV. Determination of the
surfacedensityofgold-LDL conjugateswas evaluated fromseveral samples from
each perfusion study. Thedensity is expressed as the number ofgold particles/ 1
pin length ofexternalbepatocyte surface, where the externalsurface isconsidered
as a straight line delimiting the cell boundary. This form of analysis does not
include the surface of the microvillus as part of the external hepatocyte surface.
The relative contribution of the microvillus surface is considered as equal for
both control and experimental livers and is not tabulated. Final magnification
was calibrated using areplica line grating (Polysciences, Inc., Warrington, Pa.)
and 20 micrographs were counted from each sample.
RESULTS
Effect of Estrogens on Serum and Liver Lipids
Estradiol administration for 5 d resulted in a marked de-
crease in serum cholesterol, triglyceride, and phospholipid
concentrations (Table I), accompanied by an 85% decrease in
serum very low density lipoprotein (VLDL) concentration and
an 83% decrease in HDL protein concentration. No LDL could
TABLE I
Effects of Estradiol Treatmenton Serum Cholesterol, Triglycer-
ide, and Phospholipid Concentrations
Untreated
Estradiol-treated*
Values represent pooled aliquots of serum from six rats.
* Rats were treated with estradiol (5 mg/kg) daily for 5 d.
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treatment, the rats lost 5-15 gm body weight and liver weight
increased slightly. Estradiol administration resulted in a 60%
increase in liver cholesterol concentration.
Cellular Structure of the Estradiol-treated Liver
Liver samples from estrogen-treated animals before perfu-
sion showed no alterations in cellular architecture from that
established for the normal liver (22). The sinusoidal cavity is
lined by Kupffer and endothelial cells that delimit the peri-
sinusoidal space of Disse and the microvillus structures of the
parenchymal cells. Occasional collagen bundles are evident
and several bile canaliculi, located between hepatic cells, show
adjacent rightjunctional complexes. The polyhedral-shaped
hepatic parenchymal cells contain numerous mitochondria,
lysosomes, parallel arrays ofrough endoplasmic reticulum, and
a centrally disposed nucleus. Golgi complex bodies and smooth
endoplasmic reticulum are also evident.
Viability studies based on the exclusion of ruthenium red
(Fig. 1) or horseradish peroxidase (results not shown) reveal
that the parenchymal cells, areas of cell-to-cell junctions, and
endothelial cellswere impermeable to the tracers after ethinyl-
estradiol treatment. At the microvillus, the ruthenium red stain
was observed to penetrate and fill apparently free vesicles and
tubular structures, indicating luminal continuity out of the
section plane. In the absence ofruthenium staining, it becomes
difficult to quantitate coated pits from apparently free-coated
vesicles that have released from the luminal membrane. We
did not observe separation of hepatocyte junctions or the
anomalous microvilli at lateral cell borders, as has been re-
ported to occur after estrogen treatment (9). The viability tests
were applied to liver samples from all perfusion studies and no
generalized loss of cellular integrity was observed. However,
the intense staining of ruthenium red and horseradish peroxi-
dase obscured visualization of the receptor-bound gold-LDL
conjugate. In other hepatocyte receptor studies employing fer-
ritin as a tag, ruthenium red staining is reported to obscure
surface-associated ferritin (37). Consequently, this staining pro-
tocol was used only in viability tests, not for ultrastructural
studies of conjugate binding.
Initial Events of Receptor Binding (15 min)
After 15 min of perfusion, most of the conjugates are ob-
served bound to the microvillus membranes of both normal
(Fig. 2) and estradiol-treated (Figs. 3 a and b) tissues. Although
qualitatively similar, the estradiol-treated livers showed 33.0
± 8.0 conjugates/lm length of membrane, compared to only
3.6 ± 1.1 conjugates/pin membrane length in the control
perfused livers. The structure of the conjugate seen by negative
staining (Fig. 4a) is similar to the thin-section image of the
receptor-bound conjugates (Fig. 4b). With the use of preoxi-
dized ruthenium red staining, the LDL moiety of the conjugate
can be directly visualized at the membrane surface (Fig. 4b).
Conjugates were observed as diffusely distributed along the
entire microvillus surface. The conjugate was consistently
bound to the cell receptor by the LDL molecule as the gold
granule was separated from the membrane by a distance of 20
± 3.2 run, which is equal to the diameter of LDL. Due to the
convoluted profiles of the microvillus, receptor-bound conju-
gates may appear excessively removed from or unusually close
to the microvillus. However, in most of these cases, the micro-
villus membrane is not resolvable as a bilayer but appears as
a diffuse membrane image. This results from oblique sectioning
of the bilayer, and such areas were excluded from measure-
ments of gold-membrane separation. Small coated pits were
observed only at the base of the microvillus, not at the apex or
slopes of the microvillus. After 15-min perfusion, -65-70% of
the conjugates were seen at the microvillus surface. During
internalization, 100-nm diameter coated vesicles (Fig. 4 c) were
observed to pinch off from the microvillus. Receptor-bound
conjugates usually occupy a central position within the 100-nm
vesicle, which has a symmetrical radius of curvature and is
clearly effaced with an outer cytoplasmic aspect of clathrin
material. The majority (80%) of the vesicles contain only one
gold-LDL conjugate. Delivery of the conjugate was made to
subcellular structures that resemble elementary multivesicular
bodies and possess a complete delimiting external membrane
(Fig. 5). Often, the gold shows peripheral clustering along the
inner aspect of the multivesicular bodies (MVB) membrane,
suggesting continued receptor-ligand interaction after initial
lysosomal delivery. After 15-min perfusion, 80% of the gold-
LDL (12-13 pg LDL protein/ml) remained in the perfusate.
In the presence of a 20-fold excess of unlabeled LDL, there
was a virtual absence of conjugate binding. Spectrophotometric
measurements showed that nearly 99% of gold-LDL conjugate
remained in the perfusate after 15 and 60 min of recirculating
perfusion. Besides a lack of surface-associated conjugates, ul-
trastructural examination of livertissues from estrogen-treated
animals showed a trace number of internalized gold-LDL
conjugates (results not presented).
Steady-state Hepatic Internalization (1 h)
After 1-h perfusion, the ethinylestradiol-treated livers
showed all phases of endocytosis and cellular internalization
of the gold-LDL conjugate. The elementary multivesicular
bodies seen at 15 min develop into complex MVB (26), which
contain greater numbers of gold particles and vesicles (Figs.
6 a and b). Degradation of internalized vesicles leads to the
formation of organelles having an electron-dense amorphous
appearancein which the gold is randomly distributed (Fig. 6 c).
FIGURE 1 Hepatocyte exclusion of ruthenium red stain after 15-min perfusion of the estradiol-treated liver. Intense staining
confined to the external hepatocyte membrane (H) and endothelium (E) confirms the viable status of these cells and demonstrates
bilayer integrity. The intense staining obscures visualization of receptor-bound gold-LDL conjugates. SC, sinusoidal cavity. x
10,000.
FIGURES 2-3
￿
Hepatic internalization of gold-LDL after 15-min perfusion in control and estrogen-treated livers. The conjugates
(arrowheads), visible only by the central gold particle, are bound to the microvillus membranes of both normal (Fig. 2) and
estrogen-treated rats (Fig. 3 a) . The gold particles are randomly distributed at the microvillus (MV) and shown in the enlarged
(asterisks) view (Fig. 3 b) . The estrogen-treated liver bound an 8- to 11-fold greater number of conjugates than the control sample.
Fig. 2, x 20,000; Fig. 3 a, x 20,000, and b, x 75,000.
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associated with the inner aspect ofthe membrane, is interpreted
to indicate a disruption of the conjugate-receptor complex. As
the gold-LDL conjugate is resistant to acidic dissociation (18),
the dissociation of the conjugate from the inner membrane
aspect may represent proteolytic digestion of the LDL mole-
cule, which is known to begin 15-30 min after endocytosis (8).
After 1 h of perfusion, ^-45% of the gold-LDL (6-7 hg LDL
protein/ml) remained in the perfusate.
Long-term Hepatic Internalization (2 h)
Hepatic perfusion in estradiol-treated livers for 2 h is accom-
panied by congregation of organelles containing gold in the
proximity zones of the bile canaliculi (Fig. 7). Theseorganelles
show a dense granular matrix, suggesting that they are lyso-
somes. Although all phases of cellular incorporation of the
conjugate are evident (including multivesicular, amorphous, or
electron-transparent organelles), the gold particles are easily
identified in each structure (Fig. 7). After 2-h perfusion, the
surface density of gold-LDL (29 f 7.5 conjugates/pin length
ofmembrane) is similar to that observed after 15-min perfusion
ofthe treated livers, indicating that no significant inhibition of
receptor activity occurred after the addition of LDL. Approx-
imately 25% of the gold-LDL (2.5-3.8 ,ug LDL protein/ml)
remained in the perfusate.
Nonparenchymal Cell Involvement
Although Kupffer cells do not normally express LDL recep-
tors (7), administration of estrogens is known to increase
Kupffer cell phagocytotic activity (38), which is an uptake
system related to clearance of acetylated forms of LDL (24).
The gold-LDL conjugates were observed within the stellar-
shaped Kupffer cells at all time periods of perfusion, but only
in the estradiol-treated animals (Fig. 8). Lysosomes (identified
on a morphological basis) containing gold were seen infre-
quently in the control Kupffer cells. Although we were not
able to observe a clear pattern of time-dependent internaliza-
tion, in many cases fusion of coated vesicles with the lysosome
was indicated by patches of coated membrane material inte-
grated into the lysosomal membrane (Fig. 9). Interpretation of
these vesicular structures as intracellular, rather than invagi-
nations of the plasma membrane, was based on the absence of
ruthenium red stain, which can be used as a tracer of regions
continuous with the extracellular space (19). In addition, the
gold often appeared peripherally clustered along the inner
aspect of the lysosome, suggesting continued ligand-receptor
interaction after lysosomal incorporation. These observations
indicate an endocytic mechanism ofuptake involving clathrin-
effaced vesicles. However, we did not observe the formation of
either elementary or complex MVB.
The endothelial cells at the sinusoidal cavity showed gold-
LDL at the cell surface and significant accumulation of gold
within lysosomes after 2 h of perfusion (Fig. 10). Receptor-
bound conjugates were evidenced at coated pit regions, and
delivery to lysosomes involved coated vesicles. The majority of
the lysosomes were present at the central portion of the cell
body, rather than at the peripheral fenestrated cell extremes.
MVB were not observed.
DISCUSSION
Our results show that the normal and estradiol-treated livers of
rats possess binding sites at the hepatocyte microvillus that
recognize LDL labeled with gold. Colloidal gold is a nontoxic
(44), electron-dense tracer that is easily identified by electron
microscopy(17, 18). In agreement with previous reports (8, 24,
42), estrogen treatment resulted in marked hypolipidemia with
decreased concentrations of VLDL, LDL, and high density
lipoprotein (HDL) (5). Estradiol-treated livers (Fig. 2) bind an
8- to 11-fold greater number of gold-LDL conjugates than the
normal liver(Fig. 3). Theseresults are consistentwith biochem-
ical studies showing a 3- to 10-fold increase in LDL binding
sites from isolated hepatic membranes (24, 42) and a 10-fold
increase in the catabolic rate in the perfused liver (8). Our
morphological evidence indicates that livers from both control
and estrogen-treated rats possess LDL receptors that are ran-
domly distributed on the microvillus. In the control liver, no
clear indication of the distribution of surface-associated con-
jugates (diffuse vs. clustered at coated pits) could be assessed
due to the small number present at the microvillus. In the
estradiol-treated liver, >9001o of the receptor-bound conjugates
were diffusely distributed over the entire microvillus surface.
This is in contrast to the localized binding of LDL at the coated
pit regions in cultured fibroblasts (2-4). In view ofthe 3- to 10-
fold increase in the number LDL receptors after estrogen
treatment (8, 24, 42), the altered pattern ofreceptor distribution
may reflect an inability of the coated-pit regions to accommo-
date the large increase in receptor complexes. Perhaps, by
physical necessity, redistribution into a diffuse pattern may be
required in the estrogen-augmented system. The gold particle
is separated from the membrane surface by a distance 20 ± 3
nm, which is equivalent to the diameter of LDL. Receptor
binding consistently involved the LDL moiety of the conjugate
(Fig. 4b). Although gold-LDL is observed bound along the
entire length of the microvillus, internalization via coated
vesicle formation takes place only at the base ofthe microvillus
(Fig. 4c). Receptor-mediated endocytosis involving coated-pit
FIGURE 4 Visualization of receptor-bound conjugates after 15-min perfusion in the estrogen-treated liver, made possible after
staining with oxidized ruthenium red (b), shows that the thin-section profile is similar to the conjugate structure observed by
negative staining (a) before perfusion. Preoxidation of ruthenium red before staining is necessary to reduce the intense deposition
of the stain that would otherwise obscure visualization of the conjugate (compare with Fig. 1). Endocytosis is accomplished by
coated vesicles that form and release from the microvillus base (c) . x 100,000.
FIGURE 5
￿
Internalization of gold-LDL after 15-min perfusion in the estrogen-treated liver. Formation of elementary MVB, showing
peripheral clustering of the gold at the inner aspect of the lysosomal membrane (arrowheads) . Internalized vesicles (V) appear to
lack a clathrin coat. x 100,000.
FIGURE 6
￿
After 1-h perfusion in the estrogen-treated liver, complex MVB (a-b) having large numbers of gold particles and vesicles
are seen near the bile canaliculi (BC). Also evident are amorphous organelles, in which the vesicular contents appear to be
degraded (c) . Frequently, Golgi apparatus bodies (G) are observed in the near vicinity. a, x 27,000; b, x 85,000; and c, x 85,000.
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for epidermal growth factor (26) and a2 macroglobulin (39-41).
This preferential site may indicate that randomly distributed
receptors need to migrate to the microvillus base before endo-
cytosis can begin. The necessity for receptor migration before
endocytosis may account for the longer time period ofhepatic
internalization of LDL (up to 15 min), as compared to the
shorter time sequence observed with fibroblasts (within 5 min)
(2, 4) and other cultured cell types (7) which show preferential
binding of LDL at the coated pit regions.
The 100-nm endocytosic vesicles of the liver usually contain
1 gold-LDL conjugate, in contrast to the endocytic vesicles of
the fibroblast which may contain up to 6 conjugates (18).
Endocytic vesicles of a similar diameter have been described
in the vesicular mechanism related to secretion of biliary
proteins from hepatic parenchymal cells (29), and observed in
parenchymal cell ingestion of nondegradable colloidal carbon
particles (11, 30) and endocytosis of asialoglycoproteins (33,
37). Perhaps the coated vesicles, formed at a coated region at
the microvillus base, represent a more generalized form of
vesicular transport in the liver. Thus, the coated-pit region and
the 100-nm coated vesicle ofthe liver cell may be the morpho-
logical equivalent of the coated pit-coated vesicle mechanism
detailed for the fibroblast (3).
In endocytic vesicles, the gold is separated from the delim-
itingmembrane by 20 ± 3 nm. This spatial relationship suggests
concomitant internalization of the surface receptor with the
ligand LDL. However, it is difficult to measure the gold-
membrane relationship in the vesicles because the small radius
ofvesicle curvature reduces the chances ofobserving transverse
membrane profiles. Consequently, measurements of gold-ves-
icle and gold-lysosome interactions during the formation of
MVB (Fig. 5) were selected from areas with a clear bilayer
delineation. The close apposition of the LDL moiety of the
conjugate to the vesicle bilayer during internalization is similar
to the cellular events occurring during endocytosis ofepidermal
growth factor (EGF) by cultured human carcinoma cells (26).
Although the EGF was not actually visualized, the direct
observation of LDL in our studies confirms the close associa-
tion to the receptor during endocytosis. Delivery during 15-
min perfusion is marked by formation of elementary MVB,
which contain a small number of gold particles and vesicles.
The genesis ofMVB is thought to occur by fusion of endocytic
vesicles, followed by vesicle eversion and internalization (26).
This mechanism ofMVB-vesicle fusion is reported to maintain
the polarity of interacting membranes (26). The gold is often
observed preferentially clustered along the inner aspect of the
MVB after initial vesicle fusion (Fig. 5). This mechanism of
fusion and vesicle incorporation, which has been demonstrated
in other receptor-mediated uptake systems (26), may account
for the observed distribution of the gold granules. This mech-
anism ofendocytosis suggests that the receptors are internalized
with the ligand (26) and degraded in the lysosome as a form of
down regulation. However, we did not observe any decrease in
the number of receptor-bound conjugates during the time
periods (15, 60, and 120 min) of perfusion. This observation, in
agreement with biochemical studies ofLDL uptake in estrogen-
treated livers, may indicate a dissociation of the receptor
complex from the LDL ligand after delivery to the MVB. As
the endocytic vesicles fuse to form the MVB rather than fusing
with the lysosome, it may be that the accumulation of the
ligand-receptor complex to form the MVB allows for recycling
of the receptor. The absence of the clathrin coat from vesicles
within the MVB would suggest dissociation of this component
that is related to cellular endocytosis. These results agree with
the hypothesis that coated vesicles dissociatefrom theirclathrin
cage after fusion with specific internal organelles (28). The
MVB share several ultrastructuralcharacteristics reported from
receptosomes, a recently described organelle that is believed to
a special organelle that is derived from internalized coated
vesicles (39-41). Functionally, receptosomes avoid early fusion
with lysosomes to protect potentially recyclable receptors from
lytic enzymes (41). It is perhaps from the receptosome (or
MVB) that receptors are recycled and clathrin shed from
vesicles before migration to and fusion with lysosomes. If such
is the case, then the clathrin coat may prevent fusion of
endocytic vesicles with lysosomes to prevent recyclable recep-
tors or physiologically important ligands from proteolytic
breakdown (39).
After 1-h perfusion, steady-state endocytosis ofthe conjugate
is observed within the estradiol-treated livers (Figs. 6 a-c). An
increased number of coated vesicles have been internalized to
form complex MVB (Fig. 6 a and b). During this time, there is
also the formation oforganelles that have an amorphous lumen
containing randomly distributed gold (Fig. 6 c). This type of
organelle may represent a later stage of complex MVB, in
which internalized vesicular contents have been degraded so
that membrane material is no longer resolvable. The distribu-
tion of gold as free pools within the lumen is interpreted to
indicate degradation of the gold-LDL conjugate after disrup-
tion (recycling) of the receptor complex.
After perfusion for 2 h, the estradiol-treated livers continue
to show all stages of binding, internalization, and lysosomal
accretion of the gold-LDL conjugate (Fig. 7). The surface
density of the conjugate is similar to that found at earlier liver
perfusion times, an observation that is consistent with other
reports of estradiol-treated livers, where hepatic tissues show a
decreased rate of cholesterol synthesis (13), increased content
of cholesterol esters (10), and continued and enhanced activity
of the LDL receptor (8). The lysosomes have increased in
number and changed from a random subcellular distribution
to become clustered around the bile canaliculi after 2-h per-
fusion. The majority of lysosomes near the bile canaliculi are
either amorphous or electron-transparent organelles. The elec-
tron transparency may indicate a mature status ofthe lysosome,
in which amorphous material has reached an end stage of
degradation. As such, the lysosomal contents may have been
exported to the Golgi bodies for conversion into bile. Alter-
FIGURE 7 After 2-h perfusion of the estrogen-treated liver, gold particles are seen as free pools within organelles resembling
lysosomes (L) located near the bile canalicular regions. Complex MVB and amorphous organelles (seen at 1 h) are also evident.
x 33,000.
FiGUREs 8-9 After 2-h perfusion, the gold-LDL conjugates (arrowheads) are seen within Kupffer cells (K), often peripherally
clustered along the inner aspect of electron-transparent organelles (Fig. 8) . Coated patches of membrane material are integrated
into the delimiting membrane (Fig . 9, arrowheads) . Fig. 8, X 14,000; and Fig. 9, X 37,000.
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estrogen-treated liver . Conjugates also visible at the hepatocyte microvillus underlying the endothelial cell . x 30,000.
natively, the degraded vesicle membranes and LDL molecules
may have been reduced to a state that no longer interacts with
the strains used to impart contrast to lipid structures. The
frequency of lysosomes having gold distributed as free pools
indicatescatabolism oflun3inal contents and separation ofgold
from the conjugated LDL (Fig. 7) . However, no gold was
observed in the bile canaliculi or in Golgi bodies . This may
reflect theobservations that bile flow in the livers of estradiol-
treatedanimals is reduced by -75% (8) or that nondegradable
substances (colloidal carbon, 70-nm diameter) remain in pa-
renchymal cell lysosomes up to 6 hafter endocytosis (30) . The
uptake ofgold-LDL evidenced in Kupffer cells (Figs . 8-9)may
also be a direct consequence related to estradiol treatment (38) .
As Kupffer cells are able to initiate phagocytosis of foreign
colloidal particles within minutes after injection into the cir-
culation (31, 43), we were not able to differentiate between
receptor-independent phagocytosis of the conjugateand recep-
tor-mediated endocytic mechanism . The abundancy of lyso-
somes is consistent with the large endocytotic capacity of the
Kupfer cell (36, 43).The endothelial cell internalization ofthe
conjugate (Fig. 10) may also reflect the ability of nonparen-
chymal cells to participate in uptake of serum lipoproteins (24,
34) . Thus, the cellular response of the liver to estradiol can be
interpreted as aconcertedenhancementofLDLclearancefrom
the circulation .
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